News | May 13, 2023
Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
The Awards recognizes standout digital health & medical technology products and companies
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The collaboration between CORONA and Ferring will cater to patients across India
Nous-209 has been developed using the Nouscom's viral vector platform
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Subscribe To Our Newsletter & Stay Updated
